SCARLET SALINAS: Open Payments
NPI 1316420995 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,118 in 142 payments from 21 companies in 2025. Trend: 2023 $2,343 · 2024 $2,211 · 2025 $3,118
Food & beverage: $3,118
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $390 |
| ABBVIE INC. | 15 | $345 |
| Galderma Laboratories, L.P. | 16 | $331 |
| Regeneron Healthcare Solutions, Inc. | 15 | $308 |
| Lilly USA, LLC | 9 | $277 |
| PFIZER INC. | 12 | $201 |
| Janssen Biotech, Inc. | 9 | $189 |
| Incyte Corporation | 10 | $173 |
| Amgen Inc. | 10 | $149 |
| GENZYME CORPORATION | 4 | $96 |
Products named: Bimzelx, DUPIXENT, NEMLUVIO, CIBINQO, SKYRIZI, TREMFYA, OPZELURA, TALTZ.
Industry payments across TX — which companies pay providers there.
